January 5, 2009

OneMedForum 2009: Presenting Companies Schedule

The OneMedPlace finance conference for emerging med tech companies, the OneMedForum, will be held January 13-14 in San Francisco. Our objective has been to identify the most promising and least known firms with technologies that […]

January 6 2009

Endologix Q4: Smooth Sailing Endologix, developer of Powerlink, a treatment for abdominal aortic aneurysms (AAA), posted another strong quarter. I am an unabashed fan of the company which, in November, rejected a $98 million ($2.25/share) buyout offer from New […]

January 5 2009

A Long Time Coming: Electro-Optical Sciences to Announce MelaFind Trial Results Irvington-NY based Electro-Optical Sciences (EOS), developer of The MelaFind System, a handheld imaging device that detects melanomas at an early stage, announced last week that its pivotal trial sites have closed: all follow-up data has […]

Endologix Q4: Smooth Sailing

Endologix, developer of Powerlink, a treatment for abdominal aortic aneurysms (AAA), posted another strong quarter. I am an unabashed fan of the company which, in November, rejected a $98 million ($2.25/share) buyout offer from New […]

OneMedForum 2009: Presenting Companies Schedule

The OneMedPlace finance conference for emerging med tech companies, the OneMedForum, will be held January 13-14 in San Francisco. Our objective has been to identify the most promising and least known firms with technologies that […]

A Long Time Coming: Electro-Optical Sciences to Announce MelaFind Trial Results

Irvington-NY based Electro-Optical Sciences (EOS), developer of The MelaFind System, a handheld imaging device that detects melanomas at an early stage, announced last week that its pivotal trial sites have closed: all follow-up data has […]

Minrad and Piramal to Merge

Piramal Healthcare Limited will acquire Minrad International for $.12 per share plus the assumption of debt. The total transaction, valued at approximately $40 million, is expected to close in the first quarter of 2009. Piramal, an […]

NovaDel: Longs May Finally Get a Good Night’s Sleep

The FDA has approved NovaDel’s Zolpimist, an oral spray for the short-term treatment of insomnia. Zolpimist contains zolpidem tartrate, the same active ingredient found in Ambien. Until recently, the U.S. patent for zolpidem was held […]

[Incubator Profile] UAMS BioVentures

OneMedPlace would like to welcome UAMS BioVentures as a founding member of our Portfolio Development Group. BioVentures, will discuss its innovative business practices at the upcoming OneMedForum in January. The presentation will include a snap […]

[Company Profile] OptiNose

OptiNose’s breath-actuated devices deliver intranasal drugs to targeted regions of the nasal cavity, including the sinuses and the olfactory region, without lung deposition, a major problem for traditional nasal inhalers, nasal sprays or nebulizers. OptiNose technology […]

AngioDynamics’ NanoKnife: “Unique and Remarkable” Absence of Post-Operative Pain

AngioDynamics announced the use of its Irreversible Electroporation (IRE) technology on a lymph node metastasis and the first lung lesion case. The procedures were judged successful from a safety perspective. The hospital will conduct further patient […]

CompuMed Secures $4 Million for Strategic Initiatives

CompuMed has secured a $4 million line of credit, allowing the telemedicine company to pursue strategic initiatives even in this challenging financing environment. The funds will provide immediate working capital for growth and potential acquisitions. The […]

Citing a Lack of Funds, PLC Systems Defers RenalGuard Trial

It’s been over 18 months since PLC Systems enrolled the first patients in its RenalGuard clinical trial. It now appears the company’s efforts may have been for naught. PLC has deferred the trial pending further […]